Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hims & Hers Health, Inc.HIMS · Entity 1878 | Director · Chief Executive Officer · 10% owner | August 25, 2026 | August 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hims & Hers Health, Inc.
Report date August 25, 2026 · Filed August 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of AD 2022 GRAT | 0 |
Reported balance
After 2026-08-25 transaction · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · 2026-08-25 · Gift · Disposed 463,289 · Balance 0 F2: The reported transaction involves a transfer of securities by bona fide gift for which no payment of consideration was received by the Reporting Person. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of AD 2022 GRAT | 463,289 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 463,289 F1: This amount reflects an annuity payment-in-kind of 44,741 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of Dudum Legacy 2021 Trust | 103,406 |
Reported balance
After 2026-08-27 transaction · row 5
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 5 · 2026-08-27 · Other · Disposed 977,566 · Balance 103,406 F3: This transaction represents a pro rata distribution, for no consideration, by the trust to its beneficiaries, of an aggregate of 977,566 shares of Class A Common Stock for bona fide estate planning purposes. |
| Class A Common StockSEC Table I · non-derivative | Direct | 1,033,177 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,033,177 |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 | 573,202 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 573,202 F1: This amount reflects an annuity payment-in-kind of 44,741 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of AD 2025 GRAT dated 5-27-2025 | 42,993 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 42,993 |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of Dudum Family Community Property Trust | 470,457 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 470,457 |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of AD 2022 GRAT 2 dated 9/7/2022 | 791,117 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 8
Holding and transaction disclosures are not merged.
1 source rowRow 8 · Balance 791,117 |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of Dudum Family Heritage Trust UAD 8-10-2021 | 2,214,769 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 9
Holding and transaction disclosures are not merged.
1 source rowRow 9 · Balance 2,214,769 |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Trustee of Dudum Family 2021 Trust | 3,004,071 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 10
Holding and transaction disclosures are not merged.
1 source rowRow 10 · Balance 3,004,071 |
Filing footnotes · ownership attribution and instrument terms
F1: This amount reflects an annuity payment-in-kind of 44,741 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT.
F2: The reported transaction involves a transfer of securities by bona fide gift for which no payment of consideration was received by the Reporting Person.
F3: This transaction represents a pro rata distribution, for no consideration, by the trust to its beneficiaries, of an aggregate of 977,566 shares of Class A Common Stock for bona fide estate planning purposes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 13, 2024 Filed Dec 18, 2024 00:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 3,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000394 · wk-form4_1734480100.xml · derivative · entry 18 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,576 Underlying: Class A Common Stock · 3,575 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F14 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F14 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 107 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000394 · wk-form4_1734480100.xml · derivative · entry 17 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108 Underlying: Class A Common Stock · 107 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F14 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F14 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 7,330 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000394 · wk-form4_1734480100.xml · derivative · entry 16 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,330 Underlying: Class A Common Stock · 7,330 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F14 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F14 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 35,242 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000394 · wk-form4_1734480100.xml · derivative · entry 15 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 176,210 Underlying: Class A Common Stock · 35,242 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F13 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022. F13 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 35,446 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000394 · wk-form4_1734480100.xml · derivative · entry 14 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 319,019 Underlying: Class A Common Stock · 35,446 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F12 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023. F12 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 97,062 | $30.02 | $2,913,801.24 |
DisclosureSEC source: 0001773751-24-000394 · wk-form4_1734480100.xml · nonDerivative · entry 2 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,748 F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. Read SEC document |
| December 13, 2024 Filed Dec 18, 2024 00:01 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 176,308 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-24-000394 · wk-form4_1734480100.xml · nonDerivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 209,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 21:25 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 33,513 | $33.38 | $1,118,653.89 |
DisclosureSEC source: 0001773751-24-000380 · wk-form4_1733261143.xml · nonDerivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,502 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $33.07 - $33.80. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 05, 2024 Filed Nov 7, 2024 22:15 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 188,888 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-24-000344 · wk-form4_1731017727.xml · derivative · entry 17 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 204,016 Underlying: Class A Common Stock · 188,888 shares Expires 2030-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F6 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. Read SEC document |
| November 05, 2024 Filed Nov 7, 2024 22:15 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 25,103 | $21.76 | $546,231.24 |
DisclosureSEC source: 0001773751-24-000344 · wk-form4_1731017727.xml · nonDerivative · entry 7 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,015 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $21.55 - $22.13. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 05, 2024 Filed Nov 7, 2024 22:15 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 99,987 | $21.19 | $2,119,184.47 |
DisclosureSEC source: 0001773751-24-000344 · wk-form4_1731017727.xml · nonDerivative · entry 6 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,118 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.55 - $21.54. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 05, 2024 Filed Nov 7, 2024 22:15 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 63,798 | $20.05 | $1,279,162.66 |
DisclosureSEC source: 0001773751-24-000344 · wk-form4_1731017727.xml · nonDerivative · entry 5 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 192,105 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.54 - $20.53. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 05, 2024 Filed Nov 7, 2024 22:15 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 188,888 | $2.43 | $458,997.84 |
DisclosureSEC source: 0001773751-24-000344 · wk-form4_1731017727.xml · nonDerivative · entry 4 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 255,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. Read SEC document |
| November 05, 2024 Filed Nov 7, 2024 22:15 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 12,402 | $21.76 | $269,904.73 |
DisclosureSEC source: 0001773751-24-000344 · wk-form4_1731017727.xml · nonDerivative · entry 3 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 Disclosed balance after: 506,602 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $21.55 - $22.11. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 05, 2024 Filed Nov 7, 2024 22:15 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 50,928 | $21.19 | $1,079,006.44 |
DisclosureSEC source: 0001773751-24-000344 · wk-form4_1731017727.xml · nonDerivative · entry 2 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 Disclosed balance after: 519,004 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.55 - $21.54. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 05, 2024 Filed Nov 7, 2024 22:15 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 81,114 | $20.07 | $1,627,674.08 |
DisclosureSEC source: 0001773751-24-000344 · wk-form4_1731017727.xml · nonDerivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 Disclosed balance after: 569,932 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.54 - $20.53. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:10 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 188,888 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-24-000312 · wk-form4_1727986191.xml · derivative · entry 14 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 392,904 Underlying: Class A Common Stock · 188,888 shares Expires 2030-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:10 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 144,444 | $18.22 | $2,631,394.13 |
DisclosureSEC source: 0001773751-24-000312 · wk-form4_1727986191.xml · nonDerivative · entry 4 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 Disclosed balance after: 651,046 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.00 - $18.555. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:10 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 94,444 | $18.18 | $1,716,642.48 |
DisclosureSEC source: 0001773751-24-000312 · wk-form4_1727986191.xml · nonDerivative · entry 3 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,015 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $17.97 - $18.525. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:10 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 94,444 | $18.18 | $1,716,519.70 |
DisclosureSEC source: 0001773751-24-000312 · wk-form4_1727986191.xml · nonDerivative · entry 2 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 161,459 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $17.96 - $18.51. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:10 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 188,888 | $2.43 | $458,997.84 |
DisclosureSEC source: 0001773751-24-000312 · wk-form4_1727986191.xml · nonDerivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 255,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. Read SEC document |
| September 20, 2024 Filed Sep 23, 2024 20:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 3,668 | $16.78 | $61,548.31 |
DisclosureSEC source: 0001773751-24-000305 · wk-form4_1727123730.xml · nonDerivative · entry 2 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,015 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $16.76 - $16.815. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| September 20, 2024 Filed Sep 23, 2024 20:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 42,099 | $16.29 | $685,885.33 |
DisclosureSEC source: 0001773751-24-000305 · wk-form4_1727123730.xml · nonDerivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,683 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.765 - $16.74. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 23:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 74,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000300 · wk-form4_1726614455.xml · derivative · entry 20 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,043,418 Underlying: Class A Common Stock · 74,530 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 23:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18,289 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000300 · wk-form4_1726614455.xml · derivative · entry 19 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,578 Underlying: Class A Common Stock · 18,289 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 23:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 1,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000300 · wk-form4_1726614455.xml · derivative · entry 18 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,578 Underlying: Class A Common Stock · 1,789 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 23:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 3,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000300 · wk-form4_1726614455.xml · derivative · entry 17 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,151 Underlying: Class A Common Stock · 3,575 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 23:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 106 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000300 · wk-form4_1726614455.xml · derivative · entry 16 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215 Underlying: Class A Common Stock · 106 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 23:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 7,330 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000300 · wk-form4_1726614455.xml · derivative · entry 15 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,660 Underlying: Class A Common Stock · 7,330 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 23:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 35,242 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000300 · wk-form4_1726614455.xml · derivative · entry 14 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 211,452 Underlying: Class A Common Stock · 35,242 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022. F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 23:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 35,447 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000300 · wk-form4_1726614455.xml · derivative · entry 13 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 354,465 Underlying: Class A Common Stock · 35,447 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023. F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 23:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 97,028 | $16.57 | $1,607,753.96 |
DisclosureSEC source: 0001773751-24-000300 · wk-form4_1726614455.xml · nonDerivative · entry 2 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,782 F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 23:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 176,308 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-24-000300 · wk-form4_1726614455.xml · nonDerivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 22:37 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 188,888 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-24-000283 · wk-form4_1725575814.xml · derivative · entry 11 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 581,792 Underlying: Class A Common Stock · 188,888 shares Expires 2030-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F4 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 22:37 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 144,444 | $14.50 | $2,094,828.00 |
DisclosureSEC source: 0001773751-24-000283 · wk-form4_1725575814.xml · nonDerivative · entry 3 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 Disclosed balance after: 795,490 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.305 - $14.70. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 22:37 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 188,888 | $14.56 | $2,750,095.95 |
DisclosureSEC source: 0001773751-24-000283 · wk-form4_1725575814.xml · nonDerivative · entry 2 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,502 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.42 - $14.71. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 22:37 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 188,888 | $2.43 | $458,997.84 |
DisclosureSEC source: 0001773751-24-000283 · wk-form4_1725575814.xml · nonDerivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 222,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. Read SEC document |
| August 05, 2024 Filed Aug 8, 2024 00:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 188,888 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-24-000253 · wk-form4_1723077028.xml · derivative · entry 16 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 770,680 Underlying: Class A Common Stock · 188,888 shares Expires 2030-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F7 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. Read SEC document |
| August 05, 2024 Filed Aug 8, 2024 00:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 12,903 | $16.97 | $219,023.26 |
DisclosureSEC source: 0001773751-24-000253 · wk-form4_1723077028.xml · nonDerivative · entry 6 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 Disclosed balance after: 939,934 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $16.86 - $17.055. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F6 · balance_after: This amount reflects an annuity -in-kind transfer of 62,844 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD GRAT 2022. Read SEC document |
| August 05, 2024 Filed Aug 8, 2024 00:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 131,541 | $16.53 | $2,174,675.27 |
DisclosureSEC source: 0001773751-24-000253 · wk-form4_1723077028.xml · nonDerivative · entry 5 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 Disclosed balance after: 889,993 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.86 - $16.85. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| August 05, 2024 Filed Aug 8, 2024 00:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 94,444 | $16.47 | $1,555,577.68 |
DisclosureSEC source: 0001773751-24-000253 · wk-form4_1723077028.xml · nonDerivative · entry 4 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,502 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.87 - $16.83. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| August 05, 2024 Filed Aug 8, 2024 00:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 94,344 | $16.47 | $1,553,647.56 |
DisclosureSEC source: 0001773751-24-000253 · wk-form4_1723077028.xml · nonDerivative · entry 3 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 127,946 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.87 - $16.85. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| August 05, 2024 Filed Aug 8, 2024 00:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 100 | $16.87 | $1,687.00 |
DisclosureSEC source: 0001773751-24-000253 · wk-form4_1723077028.xml · nonDerivative · entry 2 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 222,290 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. Read SEC document |
| August 05, 2024 Filed Aug 8, 2024 00:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 188,888 | $2.43 | $458,997.84 |
DisclosureSEC source: 0001773751-24-000253 · wk-form4_1723077028.xml · nonDerivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 222,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 22:45 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 188,888 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001773751-24-000217 · wk-form4_1720478714.xml · derivative · entry 14 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 959,568 Underlying: Class A Common Stock · 188,888 shares Expires 2030-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 22:45 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 144,444 | $20.69 | $2,988,763.03 |
DisclosureSEC source: 0001773751-24-000217 · wk-form4_1720478714.xml · nonDerivative · entry 4 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Indirect · Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 Disclosed balance after: 1,021,534 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.48 - $21.12. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 22:45 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 94,444 | $20.74 | $1,959,231.34 |
DisclosureSEC source: 0001773751-24-000217 · wk-form4_1720478714.xml · nonDerivative · entry 3 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,502 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.52 - $21.12. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 22:45 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 94,444 | $20.75 | $1,959,505.22 |
DisclosureSEC source: 0001773751-24-000217 · wk-form4_1720478714.xml · nonDerivative · entry 2 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 127,946 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.51 - $21.12. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 22:45 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 188,888 | $2.43 | $458,997.84 |
DisclosureSEC source: 0001773751-24-000217 · wk-form4_1720478714.xml · nonDerivative · entry 1 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 222,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. Read SEC document |
| June 20, 2024 Filed Jun 21, 2024 20:31 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 700 | $24.31 | $17,015.25 |
DisclosureSEC source: 0001773751-24-000209 · wk-form4_1719001876.xml · nonDerivative · entry 3 Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,502 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $24.03 - $24.49. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.